T-cadherin is associated with prognosis in triple-negative breast cancer.

Kong, De-Di; Wang, Mei-Hong; Yang, Jie; Li, Liang; Wang, Wei; Wang, Shi-Bing; Zhou, Yan-Zhen

Kong, De-Di; Wang, Mei-Hong; Yang, Jie; Li, Liang; Wang, Wei; Wang, Shi-Bing; Zhou, Yan-Zhen.

Affiliation

Kong DD; Department of Thyroid and Breast Surgery, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
Wang MH; Department of Thyroid and Breast Surgery, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
Yang J; Department of Pharmacy, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
Li L; Department of Pathology, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
Wang W; Department of Thyroid and Breast Surgery, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
Wang SB; Department of Thyroid and Breast Surgery, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.
Zhou YZ; Department of Thyroid and Breast Surgery, Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China.

Oncol Lett ; 14(3): 2975-2981, 2017 Sep.

Article de En | MEDLINE | ID: mdl-28928835

Mots clés

T-cadherin; clinicopathological features; prognosis; triple-negative breast cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Oncol Lett Année: 2017 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google